Intuitive Surgical, Inc. (ISRG) Stock Analysis
Recovery setup
Healthcare · Medical Instruments & Supplies
Hold if already holding. Not a fresh buy at $427.45, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: sole-sourced and single-sourced suppliers; Expensive valuation.
Intuitive Surgical makes da Vinci robotic surgical systems, Ion endoluminal systems, instruments/accessories, and training/service programs used globally across general, urologic, gynecologic, cardiothoracic, and other surgeries. Revenue comes from system placements (capital),... Read more
Hold if already holding. Not a fresh buy at $427.45, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: sole-sourced and single-sourced suppliers; Expensive valuation. Chart setup: Death cross but MACD improving, RSI 42. Maintain position. Not compelling to add more. Score 6.1/10, moderate confidence.
Passes 8/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, positive momentum, news events none recent, earnings proximity 42d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Recent developments
updated 2026-06-09Recent Developments — Intuitive Surgical, Inc.
Latest news
- NEWS Is trending stock Intuitive Surgical, Inc. (ISRG) a buy now? - MSN — MSN positive
- NEWS Intuitive Surgical Inc Stock (ISRG) Moved Down by 3.05% on Apr 29: A Full Analysis - TradingKey — TradingKey negative
- NEWS Buy UnitedHealth or Intuitive Surgical Stock After Strong Q1 Results? - TradingView — TradingView positive
- NEWS Buy UnitedHealth or Intuitive Surgical Stock After Strong Q1 Results? - Zacks Investment Research — Zacks Investment Research positive
- NEWS Why Robotic Surgery's Titan, Intuitive Surgical, Just Made A Bullish Move - Investor's Business Daily — Investor's Business Daily positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSuppliersole-sourced and single-sourced suppliers10-K Item 1A: 'Some of the components necessary for the assembly of our products are currently provided to us by sole-sourced suppliers or single-sourced suppliers due to, among other things, quality considerations'
Material Events(8-K, last 90d)
- 2026-05-04Item 5.02LOWStockholders approved amendment of 2010 Incentive Award Plan at April 30, 2026 Annual Meeting, increasing reserved shares by 5M to 125.35M total and extending plan term to January 29, 2036.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $427.45, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: sole-sourced and single-sourced suppliers; Expensive valuation. Chart setup: Death cross but MACD improving, RSI 42. Maintain position. Not compelling to add more. Target $508.73 (+19.0%), stop $401.73 (−6.4%), A.R:R 2.7:1. Score 6.1/10, moderate confidence.
Take-profit target: $508.73 (+19.2% upside). Target $508.73 (+19.0%), stop $401.73 (−6.4%), A.R:R 2.7:1. Stop-loss: $401.73.
Concentration risk — Supplier: sole-sourced and single-sourced suppliers; Expensive valuation; Below 200-MA, MA slope -1.7%/30d (confirmed downtrend).
Intuitive Surgical, Inc. trades at a P/E of 50.7 (forward 35.5). TrendMatrix value score: 3.4/10. Verdict: Hold.
40 analysts cover ISRG with a consensus score of 4.0/5. Average price target: $565.
What does Intuitive Surgical, Inc. do?Intuitive Surgical makes da Vinci robotic surgical systems, Ion endoluminal systems, instruments/accessories, and...
Intuitive Surgical makes da Vinci robotic surgical systems, Ion endoluminal systems, instruments/accessories, and training/service programs used globally across general, urologic, gynecologic, cardiothoracic, and other surgeries. Revenue comes from system placements (capital), instruments/accessories (recurring), and service contracts; OUS markets were ~32% of 2025 revenue.